Published in PLoS One on February 25, 2013
Therapeutic modification of arterial stiffness: An update and comprehensive review. World J Cardiol (2015) 0.85
Gender differences and age-specific associations between body mass index and other cardiovascular risk factors in CMV infected and uninfected people. Immunol Lett (2014) 0.79
Cytomegalovirus infection is associated with an increase in systolic blood pressure in older individuals. QJM (2016) 0.76
T cell senescence and cardiovascular diseases. Clin Exp Med (2015) 0.76
Cytomegalovirus Infection and Memory T Cell Inflation. Immune Netw (2015) 0.76
T cell immunosenescence, hypertension, and arterial stiffness. Epidemiol Health (2014) 0.75
An ELISA method to compute endpoint titers to Epstein-Barr virus and cytomegalovirus: application to population-based studies. J Immunol Methods (2014) 0.75
High anti-human cytomegalovirus antibody levels are associated with the progression of essential hypertension and target organ damage in Han Chinese population. PLoS One (2017) 0.75
Arterial Stiffness Is Associated With Cytomegalovirus-Specific Senescent CD8(+) T Cells. J Am Heart Assoc (2017) 0.75
Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (2010) 18.36
Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J (2006) 17.53
Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol (2007) 4.09
Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS One (2010) 3.64
Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol (2010) 3.52
Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation (2003) 3.15
Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation (1996) 2.64
Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection. Circulation (2011) 2.60
Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial. J Am Coll Cardiol (2009) 2.30
Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women. J Infect Dis (2012) 2.16
Matching. BMJ (1994) 1.62
Absence of association between infectious agents and endothelial function in healthy young men. Circulation (2003) 1.60
Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome. Am J Cardiol (1998) 1.55
A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Arch Intern Med (2000) 1.52
Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation. J Clin Invest (2010) 1.50
A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med (1992) 1.48
Arterial stiffness in chronic kidney disease: causes and consequences. Heart (2010) 1.29
Cytomegalovirus infection causes an increase of arterial blood pressure. PLoS Pathog (2009) 1.25
Human cytomegalovirus seropositivity is associated with impaired vascular function. Circulation (2003) 1.20
High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am J Cardiol (1998) 1.18
Infection and atherosclerosis. An alternative view on an outdated hypothesis. Pharmacol Rep (2008) 1.18
Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol (2005) 1.17
The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study. J Am Coll Cardiol (2002) 1.14
Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection. Transplantation (2006) 1.11
Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis. J Infect Dis (1998) 1.03
The role of cytomegalovirus in angiogenesis. Virus Res (2010) 0.99
Detection of human cytomegalovirus in atherosclerotic carotid arteries in humans. J Formos Med Assoc (2008) 0.98
The treatment of coronary artery disease in patients with chronic kidney disease. QJM (2006) 0.95
Relation of high cytomegalovirus antibody titres to blood pressure and brachial artery flow-mediated dilation in young men: the Cardiovascular Risk in Young Finns Study. Clin Exp Immunol (2012) 0.93
Endothelial dysfunction and cytomegalovirus replication in pediatric heart transplantation. Circulation (2008) 0.86
Detection of human cytomegalovirus in the atherosclerotic cerebral arteries in Han population in China. Acta Virol (2008) 0.81
Neointimal smooth muscle cell phenotype is important in its susceptibility to cytomegalovirus (CMV) infection: a study in rat. Cardiovasc Res (1997) 0.79
Aortic inflammation, as assessed by hybrid FDG-PET/CT imaging, is associated with enhanced aortic stiffness in addition to concurrent calcification. Eur J Nucl Med Mol Imaging (2009) 0.78
Socioeconomic status and cardiovascular disease risk. Heart (2008) 0.77
Aortic stiffness and diastolic flow abnormalities in end-stage renal disease assessed by magnetic resonance imaging. Nephron Clin Pract (2008) 0.77
Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med (2012) 6.93
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med (2009) 6.61
FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet (2007) 5.93
Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML). Blood (2012) 2.39
Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial. J Am Coll Cardiol (2009) 2.30
Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis (2010) 2.21
Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol (2004) 1.99
Progressive breathlessness in an Afro Caribbean hypertensive subject. Cardiol J (2012) 1.98
The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res Ther (2006) 1.93
Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis. Ann Rheum Dis (2009) 1.86
Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL. Blood (2005) 1.81
Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology (Oxford) (2011) 1.79
Evolution of nephrotic-associated focal segmental glomerulosclerosis and relation to the glomerular tip lesion. Kidney Int (2005) 1.72
Immunodeficiency and immunotherapy in multiple myeloma. Br J Haematol (2007) 1.69
ANCA-positive vasculitis. J Am Soc Nephrol (2002) 1.69
Cardiovascular effects of sevelamer in stage 3 CKD. J Am Soc Nephrol (2013) 1.66
Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus. Rheumatology (Oxford) (2009) 1.65
Prediction of ESRD and death among people with CKD: the Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study. Am J Kidney Dis (2010) 1.65
Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation. Blood (2005) 1.58
The haemodynamic effects of adjunctive hormone therapy in potential heart donors: a prospective randomized double-blind factorially designed controlled trial. Eur Heart J (2009) 1.54
3-year follow-up of 100 consecutive coronary bifurcation lesions treated with Taxus stents and the crush technique. Catheter Cardiovasc Interv (2010) 1.44
Reducing mortality in myocardial infarction. BMJ (2005) 1.44
Echocardiography in the potential heart donor. Transplantation (2010) 1.41
Kissing drug eluting balloons for in-stent restenosis complicating bifurcations treated with drug-eluting stents. Catheter Cardiovasc Interv (2012) 1.40
Imaging features in Takotsubo cardiomyopathy. BMJ Case Rep (2013) 1.39
Effects of nitroglycerin treatment on cardiac autonomic control in heart failure. Clin Auton Res (2004) 1.38
Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial. J Clin Oncol (2012) 1.36
Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells. Blood (2003) 1.33
Anti-neutrophil cytoplasm-associated glomerulonephritis. J Am Soc Nephrol (2006) 1.29
Arterial stiffness in chronic kidney disease: causes and consequences. Heart (2010) 1.29
The age-related increase in low-grade systemic inflammation (Inflammaging) is not driven by cytomegalovirus infection. Aging Cell (2012) 1.24
A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis. Arthritis Care Res (Hoboken) (2011) 1.23
Immunosenescence and Cytomegalovirus: where do we stand after a decade? Immun Ageing (2010) 1.22
Report from the second cytomegalovirus and immunosenescence workshop. Immun Ageing (2011) 1.19
Selective accumulation of virus-specific CD8+ T cells with unique homing phenotype within the human bone marrow. Blood (2008) 1.19
CMV and Immunosenescence: from basics to clinics. Immun Ageing (2012) 1.17
Subclinical abnormalities of left ventricular myocardial deformation in early-stage chronic kidney disease: the precursor of uremic cardiomyopathy? J Am Soc Echocardiogr (2008) 1.16
Biology and management of relapsed acute myeloid leukaemia. Br J Haematol (2005) 1.13
Reproducibility of derived central arterial waveforms in patients with chronic renal failure. Clin Sci (Lond) (2002) 1.12
Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study. Arthritis Rheum (2009) 1.11
Arterial disease in chronic kidney disease. Heart (2012) 1.11
CD8+ T cells specific for cancer germline gene antigens are found in many patients with multiple myeloma, and their frequency correlates with disease burden. Blood (2005) 1.10
Patients with Wegener's granulomatosis demonstrate a relative deficiency and functional impairment of T-regulatory cells. Immunology (2010) 1.10
The SEM6A6 locus is not associated with granulomatosis with polyangiitis or other forms of antineutrophil cytoplasmic antibody-associated vasculitides in Europeans: comment on the article by Xie et al. Arthritis Rheumatol (2014) 1.09
Type I interferon (IFN alpha) acts directly on human memory CD4+ T cells altering their response to antigen. J Immunol (2009) 1.09
Adverse effects of therapy for ANCA-associated vasculitis. Best Pract Res Clin Rheumatol (2009) 1.07
Serum phosphate but not pulse wave velocity predicts decline in renal function in patients with early chronic kidney disease. Nephrol Dial Transplant (2011) 1.06
Chimeric IgG4 PR3-ANCA induces selective inflammatory responses from neutrophils through engagement of Fcgamma receptors. Immunology (2009) 1.05
Serum phosphate is associated with left ventricular mass in patients with chronic kidney disease: a cardiac magnetic resonance study. Heart (2011) 1.05
Intravenous cyclophosphamide and plasmapheresis in dialysis-dependent ANCA-associated vasculitis. Clin J Am Soc Nephrol (2012) 1.05
Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells. Blood (2002) 1.04
Dendritic cell uptake of human apoptotic and necrotic neutrophils inhibits CD40, CD80, and CD86 expression and reduces allogeneic T cell responses: relevance to systemic vasculitis. Arthritis Rheum (2003) 1.03
Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: cause or association? Atherosclerosis (2012) 1.02
New findings in pathogenesis of antineutrophil cytoplasm antibody-associated vasculitis. Curr Opin Rheumatol (2002) 1.01
Effects of sodium bicarbonate ingestion on prolonged intermittent exercise. Med Sci Sports Exerc (2003) 0.99
Atrial fibrillation in CKD: balancing the risks and benefits of anticoagulation. Am J Kidney Dis (2013) 0.98
The role of echocardiography in percutaneous left atrial appendage occlusion. Eur J Echocardiogr (2011) 0.96
Reconstitution of T-cell repertoire after autologous stem cell transplantation: influence of CD34 selection and cytomegalovirus infection. Biol Blood Marrow Transplant (2003) 0.96
Cardiac vagal response to water ingestion in normal human subjects. Clin Sci (Lond) (2002) 0.94
Recurrences and infections during continuous immunosuppressive therapy after beginning dialysis in ANCA-associated vasculitis. Am J Kidney Dis (2007) 0.94
Comparison of magnetic resonance feature tracking for systolic and diastolic strain and strain rate calculation with spatial modulation of magnetization imaging analysis. J Magn Reson Imaging (2014) 0.93
Effect of spironolactone on left ventricular systolic and diastolic function in patients with early stage chronic kidney disease. Am J Cardiol (2010) 0.93
Nitric oxide and cardiac parasympathetic control in human heart failure. Clin Sci (Lond) (2002) 0.93